{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:37:20Z","timestamp":1790285840705,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11102-024-01494-w","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T21:23:10Z","timestamp":1738617790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Assessment of sarcopenic obesity in patients with acromegaly"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2713-3543","authenticated-orcid":false,"given":"Claudia Pinheiro Sanches","family":"Rocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3396-4418","authenticated-orcid":false,"given":"Nat\u00e1lia Nachbar","family":"Hupalowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6101-4359","authenticated-orcid":false,"given":"Vicente Florentino Castaldo","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-7941","authenticated-orcid":false,"given":"Cesar Luiz","family":"Boguszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0555-0880","authenticated-orcid":false,"given":"Vict\u00f3ria Zeghbi Cochenski","family":"Borba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"1494_CR1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41574-018-0062-9","volume":"14","author":"JA Batsis","year":"2018","unstructured":"Batsis JA, Villareal DT (2018) Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol 14:513\u2013537. https:\/\/doi.org\/10.1038\/s41574-018-0062-9","journal-title":"Nat Rev Endocrinol"},{"key":"1494_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-023-00943-z","volume":"20","author":"CM Prado","year":"2024","unstructured":"Prado CM, Batsis JA, Donini LM et al (2024) Sarcopenic obesity in older adults: a clinical overview. Nat Rev Endocrinol 20:261\u2013277. https:\/\/doi.org\/10.1038\/s41574-023-00943-z","journal-title":"Nat Rev Endocrinol"},{"key":"1494_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2020.00332","volume":"11","author":"E Roh","year":"2020","unstructured":"Roh E, Choi KM (2020) Health consequences of sarcopenic obesity: a narrative review. Front Endocrinol (Lausanne) 11:1\u201312. https:\/\/doi.org\/10.3389\/fendo.2020.00332","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1494_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000521241","volume":"15","author":"LM Donini","year":"2022","unstructured":"Donini LM, Busetto L, Bischoff SC et al (2022) Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO Consensus Statement. Obes Facts 15:321\u2013335. https:\/\/doi.org\/10.1159\/000521241","journal-title":"Obes Facts"},{"key":"1494_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0071-6","author":"A Colao","year":"2019","unstructured":"Colao A, Grasso LFS, Giustina A et al (2019) Acromegaly. Nat Rev Dis Primers. https:\/\/doi.org\/10.1038\/s41572-019-0071-6. 5:","journal-title":"Nat Rev Dis Primers"},{"key":"1494_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11102-023-01360-1","volume":"27","author":"A Giustina","year":"2024","unstructured":"Giustina A, Biermasz N, Casanueva FF et al (2024) Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27:7\u201322. https:\/\/doi.org\/10.1007\/s11102-023-01360-1","journal-title":"Pituitary"},{"key":"1494_CR7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1210\/clinem\/dgz096\/5586717","volume":"105","author":"A Giustina","year":"2020","unstructured":"Giustina A, Barkan A, Beckers A et al (2020) A Consensus on the diagnosis and treatment of Acromegaly comorbidities: an update. J Clin Endocrinol Metab 105:937\u2013946. https:\/\/doi.org\/10.1210\/clinem\/dgz096\/5586717","journal-title":"J Clin Endocrinol Metab"},{"key":"1494_CR8","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1530\/EJE-20-0281","volume":"183","author":"CL Boguszewski","year":"2020","unstructured":"Boguszewski CL (2020) Acromegaly: you must know it to think of it. Eur J Endocrinol 183:C1\u2013C4. https:\/\/doi.org\/10.1530\/EJE-20-0281","journal-title":"Eur J Endocrinol"},{"key":"1494_CR9","doi-asserted-by":"publisher","unstructured":"Milioto A, Corica G, Nista F et al (2024) Skeletal muscle evaluation in patients with acromegaly. J Endocr Soc 8. https:\/\/doi.org\/10.1210\/jendso\/bvae032","DOI":"10.1210\/jendso\/bvae032"},{"key":"1494_CR10","doi-asserted-by":"publisher","unstructured":"Guo X, Gao L, Shi X et al (2018) Pre- and Postoperative Body Composition and Metabolic Characteristics in Patients with Acromegaly: A Prospective Study. Int J Endocrinol 2018:. https:\/\/doi.org\/10.1155\/2018\/4125013","DOI":"10.1155\/2018\/4125013"},{"key":"1494_CR11","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s11102-015-0657-2","volume":"18","author":"TJ Reid","year":"2015","unstructured":"Reid TJ, Jin Z, Shen W et al (2015) IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition. Pituitary 18:808\u2013819. https:\/\/doi.org\/10.1007\/s11102-015-0657-2","journal-title":"Pituitary"},{"key":"1494_CR12","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s11102-023-01352-1","volume":"26","author":"S Coskun Meric","year":"2023","unstructured":"Coskun Meric S, Halit C, Mahi et al (2023) Assessment of forearm muscles with ultrasound shear wave elastography in patients with acromegaly. Pituitary 26:716\u2013724. https:\/\/doi.org\/10.1007\/s11102-023-01352-1","journal-title":"Pituitary"},{"key":"1494_CR13","doi-asserted-by":"publisher","unstructured":"Freda PU (2022) The acromegaly lipodystrophy. Front Endocrinol (Lausanne) 13. https:\/\/doi.org\/10.3389\/fendo.2022.933039","DOI":"10.3389\/fendo.2022.933039"},{"key":"1494_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1530\/EJE-21-0209","volume":"185","author":"L Martel-Duguech","year":"2021","unstructured":"Martel-Duguech L, Alonso-P\u00e9rez J, Bascu\u00f1ana H et al (2021) Intramuscular fatty infiltration and physical function in controlled acromegaly. Eur J Endocrinol 185:167\u2013177. https:\/\/doi.org\/10.1530\/EJE-21-0209","journal-title":"Eur J Endocrinol"},{"key":"1494_CR15","doi-asserted-by":"publisher","unstructured":"Lopes AA, Albuquerque L, Fontes M et al (2022) Body composition in Acromegaly according to Disease activity\u2013 performance of dual X-Ray Absorptiometry and Multifrequency Bioelectrical Impedance Analysis. Front Endocrinol (Lausanne) 13. https:\/\/doi.org\/10.3389\/fendo.2022.866099","DOI":"10.3389\/fendo.2022.866099"},{"key":"1494_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12020-023-03317-7","volume":"80","author":"A Giustina","year":"2023","unstructured":"Giustina A, di Filippo L, Uygur MM, Frara S (2023) Modern approach to resistant acromegaly. Endocrine 80:303\u2013307. https:\/\/doi.org\/10.1007\/s12020-023-03317-7","journal-title":"Endocrine"},{"key":"1494_CR17","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/ajcn\/72.3.694","volume":"72","author":"SB Dympna Gallagher","year":"2000","unstructured":"Dympna Gallagher SB, Heymsfield M, Heo et al (2000) Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am Soc Clin Nutr 72:694\u2013701. https:\/\/doi.org\/10.1093\/ajcn\/72.3.694","journal-title":"Am Soc Clin Nutr"},{"key":"1494_CR18","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/jgs.12260","volume":"61","author":"JA Batsis","year":"2013","unstructured":"Batsis JA, Barre LK, Mackenzie TA et al (2013) Variation in the prevalence of Sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999\u20132004. J Am Geriatr Soc 61:974\u2013980. https:\/\/doi.org\/10.1111\/jgs.12260","journal-title":"J Am Geriatr Soc"},{"key":"1494_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169","journal-title":"Age Ageing"},{"key":"1494_CR20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1177\/0898264312438551","volume":"24","author":"AN Freire","year":"2012","unstructured":"Freire AN, Guerra RO, Alvarado B et al (2012) Validity and reliability of the short physical performance battery in two diverse older adult populations in Quebec and Brazil. J Aging Health 24:863\u2013878. https:\/\/doi.org\/10.1177\/0898264312438551","journal-title":"J Aging Health"},{"key":"1494_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"K TAN","year":"2004","unstructured":"TAN K, WHO expert consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157\u2013163","journal-title":"Lancet"},{"key":"1494_CR22","doi-asserted-by":"publisher","unstructured":"Imboden MT, Welch WA, Swartz AM et al (2017) Reference standards for body fat measures using GE dual energy x-ray absorptiometry in caucasian adults. PLoS ONE 12. https:\/\/doi.org\/10.1371\/journal.pone.0175110","DOI":"10.1371\/journal.pone.0175110"},{"key":"1494_CR23","doi-asserted-by":"publisher","unstructured":"Soh BLP, Lee SY, Wong WY et al (2022) Body composition reference values in Singaporean adults using dual-energy X-ray absorptiometry\u2014the Yishun study. PLoS ONE 17. https:\/\/doi.org\/10.1371\/journal.pone.0276434","DOI":"10.1371\/journal.pone.0276434"},{"key":"1494_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1046\/j.1365-2265.2000.00910.x","volume":"52","author":"P Lucidi","year":"2000","unstructured":"Lucidi P, Laureti S, Santoni S et al (2000) Administration of recombinant human growth hormone on alternate days is sufficient to increase whole body protein synthesis and lipolysis in growth hormone deficient adults. Clin Endocrinol (Oxf) 52:173\u2013179. https:\/\/doi.org\/10.1046\/j.1365-2265.2000.00910.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1494_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11102-008-0104-8","volume":"12","author":"L Katznelson","year":"2009","unstructured":"Katznelson L (2009) Alterations in body composition in acromegaly. Pituitary 12:136\u2013142. https:\/\/doi.org\/10.1007\/s11102-008-0104-8","journal-title":"Pituitary"},{"key":"1494_CR26","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1136\/bmj.2.6041.914","volume":"2","author":"M Nagulesparen","year":"1976","unstructured":"Nagulesparen M, Trickey R, Davies MJ, Jenkins JS (1976) Muscle changes in acromegaly. Br Med J 2:914\u2013915. https:\/\/doi.org\/10.1136\/bmj.2.6041.914","journal-title":"Br Med J"},{"key":"1494_CR27","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1210\/jc.2015-1917","volume":"100","author":"CM Reyes-Vidal","year":"2015","unstructured":"Reyes-Vidal CM, Mojahed H, Shen W et al (2015) Adipose tissue redistribution and ectopic lipid deposition in active acromegaly and effects of surgical treatment. J Clin Endocrinol Metab 100:2946\u20132955. https:\/\/doi.org\/10.1210\/jc.2015-1917","journal-title":"J Clin Endocrinol Metab"},{"key":"1494_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/cen.12505","volume":"82","author":"KB Min","year":"2015","unstructured":"Min KB, Min JY (2015) Android and gynoid fat percentages and serum lipid levels in United States adults. Clin Endocrinol (Oxf) 82:377\u2013387. https:\/\/doi.org\/10.1111\/cen.12505","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1494_CR29","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1210\/jc.2008-0804","volume":"93","author":"P Wiklund","year":"2008","unstructured":"Wiklund P, Toss F, Weinehall L et al (2008) Abdominal and gynoid fat mass are associated with cardiovascular risk factors in men and women. J Clin Endocrinol Metab 93:4360\u20134366. https:\/\/doi.org\/10.1210\/jc.2008-0804","journal-title":"J Clin Endocrinol Metab"},{"key":"1494_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jocd.2022.01.006","volume":"25","author":"K Zhu","year":"2022","unstructured":"Zhu K, Walsh JP, Murray K et al (2022) DXA-Derived vs Standard Anthropometric Measures for Predicting Cardiometabolic Risk in Middle-aged Australian men and women. J Clin Densitometry 25:299\u2013307. https:\/\/doi.org\/10.1016\/j.jocd.2022.01.006","journal-title":"J Clin Densitometry"},{"key":"1494_CR31","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/ijo.2017.289","volume":"42","author":"SK Vasan","year":"2018","unstructured":"Vasan SK, Osmond C, Canoy D et al (2018) Comparison of regional fat measurements by dual-energy X-ray absorptiometry and conventional anthropometry and their association with markers of diabetes and cardiovascular disease risk. Int J Obes 42:850\u2013857. https:\/\/doi.org\/10.1038\/ijo.2017.289","journal-title":"Int J Obes"},{"key":"1494_CR32","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s40618-024-02340-3","volume":"47","author":"V Cimolin","year":"2024","unstructured":"Cimolin V, Premoli C, Bernardelli G et al (2024) ACROMORFO study: gait analysis in a cohort of acromegalic patients. J Endocrinol Invest 47:2469\u20132476. https:\/\/doi.org\/10.1007\/s40618-024-02340-3","journal-title":"J Endocrinol Invest"},{"key":"1494_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.gaitpost.2014.03.014","volume":"40","author":"AJ Lopes","year":"2014","unstructured":"Lopes AJ, da Silva DPG, Kasuki L et al (2014) Posture and balance control in patients with acromegaly: results of a cross-sectional study. Gait Posture 40:154\u2013159. https:\/\/doi.org\/10.1016\/j.gaitpost.2014.03.014","journal-title":"Gait Posture"},{"key":"1494_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1530\/EJE-17-0120","volume":"177","author":"L F\u00fcchtbauer","year":"2017","unstructured":"F\u00fcchtbauer L, Olsson DS, Bengtsson B-\u00c5 et al (2017) Muscle strength in patients with acromegaly at diagnosis and during long-term Follow-up. Short title: muscle function in Acromegaly authors. Eur Soc Endocrinol 177:217\u2013226. https:\/\/doi.org\/10.1530\/EJE-17-0120","journal-title":"Eur Soc Endocrinol"},{"key":"1494_CR35","doi-asserted-by":"publisher","unstructured":"Purcell SA, Mackenzie M, Barbosa-Silva TG et al (2021) Prevalence of sarcopenic obesity using different definitions and the relationship with strength and physical performance in the Canadian longitudinal study of aging. https:\/\/doi.org\/10.3389\/fphys.2020.583825. Front Physiol 11:","DOI":"10.3389\/fphys.2020.583825"},{"key":"1494_CR36","doi-asserted-by":"publisher","unstructured":"Moreira MA, Zunzunegui MV, Vafaei A et al (2016) Sarcopenic obesity and physical performance in middle aged women: a cross-sectional study in Northeast Brazil. BMC Public Health 16. https:\/\/doi.org\/10.1186\/s12889-015-2667-4","DOI":"10.1186\/s12889-015-2667-4"},{"key":"1494_CR37","doi-asserted-by":"publisher","unstructured":"da Silva LSL, Abdalla PP, Marcos-Pardo PJ et al (2024) Sarcopenic obesity does not impair lower limb strength and physical performance in sufficiently active older adults: a cross-sectional study. Sci Rep 14. https:\/\/doi.org\/10.1038\/s41598-024-53538-7","DOI":"10.1038\/s41598-024-53538-7"},{"key":"1494_CR38","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1530\/EJE-20-0019","volume":"182","author":"D Esposito","year":"2020","unstructured":"Esposito D, Ragnarsson O, Johannsson G, Olsson DS (2020) Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality. Eur J Endocrinol 182:523\u2013531. https:\/\/doi.org\/10.1530\/EJE-20-0019","journal-title":"Eur J Endocrinol"},{"key":"1494_CR39","doi-asserted-by":"publisher","unstructured":"Vila G, J\u00f8rgensen JOL, Luger A, Stalla GK (2019) Insulin resistance in patients with acromegaly. Front Endocrinol (Lausanne) 10. https:\/\/doi.org\/10.3389\/fendo.2019.00509","DOI":"10.3389\/fendo.2019.00509"},{"key":"1494_CR40","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1210\/jc.2007-2780","volume":"93","author":"PU Freda","year":"2008","unstructured":"Freda PU, Shen W, Heymsfield SB et al (2008) Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly. J Clin Endocrinol Metab 93:2334\u20132343. https:\/\/doi.org\/10.1210\/jc.2007-2780","journal-title":"J Clin Endocrinol Metab"},{"key":"1494_CR41","doi-asserted-by":"publisher","unstructured":"Kuker AP, Shen W, Jin Z et al (2021) Body composition changes with long-term Pegvisomant Therapy of Acromegaly. J Endocr Soc 5. https:\/\/doi.org\/10.1210\/jendso\/bvab004","DOI":"10.1210\/jendso\/bvab004"},{"key":"1494_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1530\/EJE-21-0900","volume":"186","author":"P Wolf","year":"2021","unstructured":"Wolf P, Salenave S, Durand E et al (2021) Treatment of acromegaly has substantial effects on body composition: a long-term follow-up study. Eur J Endocrinol 186:173\u2013181. https:\/\/doi.org\/10.1530\/EJE-21-0900","journal-title":"Eur J Endocrinol"},{"key":"1494_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/cen.12708","volume":"83","author":"E Hatipoglu","year":"2015","unstructured":"Hatipoglu E, Topsakal N, Erkut Atilgan O et al (2015) Physical and cardiovascular performance in cases with acromegaly after regular short-term exercise. Clin Endocrinol (Oxf) 83:91\u201397. https:\/\/doi.org\/10.1111\/cen.12708","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1494_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12020-019-02011-x","volume":"66","author":"TRL Lima","year":"2019","unstructured":"Lima TRL, Kasuki L, Gadelha M, Lopes AJ (2019) Physical exercise improves functional capacity and quality of life in patients with acromegaly: a 12-week follow-up study. Endocrine 66:301\u2013309. https:\/\/doi.org\/10.1007\/s12020-019-02011-x","journal-title":"Endocrine"},{"key":"1494_CR45","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11102-019-00979-3","volume":"22","author":"O Haliloglu","year":"2019","unstructured":"Haliloglu O, Topsakal N, Camliguney F et al (2019) Static and dynamic balances of patients with acromegaly and impact of exercise on balance. Pituitary 22:497\u2013506. https:\/\/doi.org\/10.1007\/s11102-019-00979-3","journal-title":"Pituitary"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01494-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01494-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01494-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T14:33:32Z","timestamp":1741444412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01494-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1494"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01494-w","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"25 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CLB has received lecture fees and served as a consultant from Ipsen, Recordati, and Novo Nordisk, and has been the principal investigator of clinical trials of Novartis, and Recordati. The other authors have nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}],"article-number":"25"}}